Clinical depression and inflammatory risk markers for coronary heart disease (Q37870585)

24 August 2017

title

Clinical depression and inflammatory risk markers for coronary heart disease (English)

1 reference

24 August 2017

0 references

Gregory E Miller

1

1 reference

24 August 2017

Cinnamon A Stetler

2

1 reference

24 August 2017

Robert M Carney

3

1 reference

24 August 2017

Kenneth E Freedland

4

1 reference

24 August 2017

William A Banks

5

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

American Journal of Cardiology

24 August 2017

published in

1 reference

24 August 2017

volume

90

1 reference

24 August 2017

issue

12

1 reference

24 August 2017

page(s)

1279-1283

1 reference

Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Major depressive disorder predicts cardiac events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Depression following myocardial infarction. Impact on 6-month survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Depression and the course of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Current concepts of the pathogenesis of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗∗The opinions and assertions expressed herein are those of the authors and are not to be construed as reflect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Association of interleukin-6 and other biologic variables with depression in older people living in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Life stress, mood disturbance, and elevated interleukin-6 in healthy older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Inflammation, depressive symptomtology, and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

The pathophysiologic roles of interleukin-6 in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902863-1

10.1016/S0002-9149(02)02863-1

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference